Hexagon Nutrition Ltd

AI

Hexagon Nutrition Ltd

₹ 69.4 1.22%
09 Oct - close price
About

Incorporated in 1993, Hexagon Nutrition
Ltd is a research-driven nutrition company.[1]

Key Points

Business Profile:[1]
Hexagon Nutrition is a research-
driven nutrition company engaged
in the development, manufacturing
and marketing of nutrition products
across micronutrient premixes, branded
wellness and clinical nutrition, therapeutic formulations, ready-to-use foods (RUFs)
and micronutrient powders (MNPs).

  • Market Cap ₹ 853 Cr.
  • Current Price ₹ 69.4
  • High / Low ₹ 78.7 / 48.0
  • Stock P/E 21.6
  • Book Value ₹
  • Dividend Yield 0.43 %
  • ROCE 22.2 %
  • ROE 16.8 %
  • Face Value ₹ 1.00

Pros

  • Company has delivered good profit growth of 50.3% CAGR over last 5 years

Cons

  • Earnings include an other income of Rs.15.6 Cr.
  • Working capital days have increased from 105 days to 168 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2025 Jun 2025 Dec 2025 Mar 2026 Jun 2026
83.45 63.26 81.89 98.47 101.40
74.86 55.65 69.59 84.48 89.09
Operating Profit 8.59 7.61 12.30 13.99 12.31
OPM % 10.29% 12.03% 15.02% 14.21% 12.14%
2.20 2.12 3.00 6.47 3.03
Interest 0.52 0.40 0.44 0.62 0.67
Depreciation 1.35 1.34 1.44 1.65 1.43
Profit before tax 8.92 7.99 13.42 18.19 13.24
Tax % 25.56% 25.28% 26.38% 25.07% 25.68%
6.64 5.97 9.88 13.63 9.83
EPS in Rs 0.60 0.54 0.89 1.23 0.80
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
99 86 107 114 132 267 316
88 79 94 115 119 233 273
Operating Profit 10 7 13 -1 13 34 43
OPM % 11% 9% 12% -0.8% 10% 13% 14%
1 3 2 2 5 10 16
Interest 1 1 1 1 1 2 2
Depreciation 3 2 2 3 3 5 6
Profit before tax 8 7 13 -3 14 36 51
Tax % 7% 24% 29% 18% 25% 26% 26%
7 6 9 -3 10 27 38
EPS in Rs 0.67 0.51 0.81 -0.28 0.95 2.44 3.45
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 30%
3 Years: 41%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: 50%
3 Years: 266%
TTM: 41%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 15%
3 Years: 17%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 11 11 11 11 11 11 11
Reserves 35 37 56 51 61 181 220
26 25 22 28 40 12 25
24 21 26 36 28 36 49
Total Liabilities 96 94 116 126 141 241 305
21 20 20 22 25 40 41
CWIP 0 0 2 1 2 1 1
Investments 12 16 20 16 8 32 34
62 58 74 86 107 168 230
Total Assets 96 94 116 126 141 241 305

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
10 5 1 7 -2 21 8
-1 -2 -11 -8 -8 -5 -20
-5 -4 7 3 11 -20 11
Net Cash Flow 5 -1 -3 2 1 -3 -1
Free Cash Flow 9 5 -4 2 -8 16 3
CFO/OP 113% 75% 31% -852% 5% 91% 45%

Ratios

Standalone / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 50 57 52 76 67 81 90
Inventory Days 128 149 192 150 146 132 145
Days Payable 108 95 108 152 80 48 61
Cash Conversion Cycle 71 110 136 74 132 164 174
Working Capital Days 89 58 76 65 1 147 168
ROCE % 10% 15% 2% 15% 23% 22%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Capacity Utilization - Clinical Nutrition
%

Log in to view insights

Please log in to see hidden values.

Login
Export Revenue Share (Rest of World)
% of revenue
Top 10 Customer Revenue Concentration
% of revenue
Branded Nutrition Segment Revenue Share
% of revenue
Number of Distributors
count
Number of Permanent Employees (Consolidated)
count
Production Volume - Dry Pre-mix
MT
Production Volume - Ready-to-Use Food (RUF/RUTF)
MT
Capacity Utilization - Blended (All Products)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

16 Recently
Jun 2026
64.29%
0.29%
6.42%
28.99%
No. of Shareholders 20,187

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents